Related Experiment Video
Updated: Aug 12, 2026

Analysis of Cell Cycle Position in Mammalian Cells
Published on: January 21, 2012
Cyclin D1 suppresses retinoblastoma protein-mediated inhibition of TAFII250 kinase activity
J L Siegert1, J J Rushton, W R Sellers
1Department of Molecular Genetics and Biochemistry, University of Pittsburgh School of Medicine, Pennsylvania 15261, USA.
Abstract:
The retinoblastoma tumor suppressor protein has been shown to bind directly and inhibit a transcriptionally-important amino-terminal kinase domain of TATA-binding protein-associated factor TAFII250. Cyclin D1 also is able to associate with the amino terminus of TAFII250 in a region very similar to or overlapping the Rb-binding site. In this study, we have examined whether cyclin D1 affects the functional interaction between Rb and TAFII250. We observed that when cyclin D1 is coincubated with Rb and TAFII250, the ability of Rb to inhibit TAFII250 kinase activity is effectively blocked. However, cyclin D1 by itself has no apparent effect on TAFII250 kinase activity. We further found that the Rb-related protein p107 can inhibit TAFII250 kinase activity, and this inhibition is likewise alleviated by cyclin D1. Cyclin D1 prevents the kinase-inhibitory effect of an Rb mutant unable to bind to D-type cyclins, indicating that it is acting through its association with TAFII250 and not with Rb. However, we found no evidence of TAFII250-binding competition between Rb and cyclin D1 in vitro. The adenovirus E1A protein, which also binds to both Rb and TAFII250, exhibited a suppressive effect on Rb-mediated kinase inhibition similar to that seen with cyclin D1. Our results suggest a novel means by which cyclin D1 may be able to independently regulate the activity of Rb.
Insights
Cyclin D1 blocks retinoblastoma protein (Rb) inhibition of TAFII250 kinase activity. This suggests cyclin D1 independently regulates Rb activity by interacting with TAFII250, not Rb.
Area of Science:
- Molecular Biology
- Cell Cycle Regulation
- Tumor Suppressor Proteins
Background:
- Retinoblastoma protein (Rb) inhibits TAFII250 kinase activity.
- Cyclin D1 binds to TAFII250 near the Rb-binding site.
Purpose of the Study:
- Investigate if cyclin D1 affects the Rb-TAFII250 interaction.
- Determine the mechanism by which cyclin D1 influences TAFII250 kinase activity.
Main Methods:
- In vitro kinase assays.
- Coincubation of Rb, cyclin D1, and TAFII250.
- Use of Rb mutants and adenovirus E1A protein.
Main Results:
- Cyclin D1 blocks Rb-mediated inhibition of TAFII250 kinase activity.
- Cyclin D1 does not affect TAFII250 kinase activity alone.
- p107 inhibition of TAFII250 is also alleviated by cyclin D1.
- Cyclin D1 acts via TAFII250, not Rb, and does not compete with Rb for binding.
- Adenovirus E1A protein mimics cyclin D1's effect.
Conclusions:
- Cyclin D1 regulates Rb activity through TAFII250.
- Cyclin D1 may independently modulate Rb function.
- This interaction offers a novel regulatory mechanism for Rb activity.
More Related Videos
Related Concept Videos
Positive Regulator Molecules
Negative Regulator Molecules
Positive Regulator Molecules
Inhibition of Cdk Activity
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Inhibition of CDK Activity

